Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
dTub
Скачать

Tutorial: Review your eCTD submissions with GlobalSubmit WebReview

Автор: Certara

Загружено: 2020-12-08

Просмотров: 14453

Описание:

Reviewers are often tasked with quickly approving eCTD submission content and fielding agency questions on the fly, which requires referencing in-stream as well as historical submissions. The trouble is, without the right eCTD viewing solutions in place, simple yet critical review tasks can cause delays, increasing your risk of rejection, costs, and user frustration.

Certara’s GlobalSubmit WebReview is a cloud-based eCTD reviewer that facilitates an efficient and dynamic regulatory review of your eCTD submission process through cloud-powered, web-hosted access for all your global activities. Start your 30-day free trial today: https://www.certara.com/globalsubmit-...

Tutorial: Review your eCTD submissions with GlobalSubmit WebReview

Поделиться в:

Доступные форматы для скачивания:

Скачать видео mp4

  • Информация по загрузке:

Скачать аудио mp3

Похожие видео

Vault Submissions Publishing Demo

Vault Submissions Publishing Demo

eCTD and CTD in Regulatory Affairs | The FASTEST Way to Master eCTD and CTD in Regulatory Affairs

eCTD and CTD in Regulatory Affairs | The FASTEST Way to Master eCTD and CTD in Regulatory Affairs

CTD / eCTD regulatory submissions

CTD / eCTD regulatory submissions

Investigational New Drug (IND) Submission: Content/Format and First 30 Days (5of14) REdI 2018

Investigational New Drug (IND) Submission: Content/Format and First 30 Days (5of14) REdI 2018

LORENZ docuBridge (RAPS Demo)

LORENZ docuBridge (RAPS Demo)

A Short Guide to the ICH CTD (Common Technical Document)

A Short Guide to the ICH CTD (Common Technical Document)

Empowering Trial Design and Optimal Dosing with Simcyp Simulator V24

Empowering Trial Design and Optimal Dosing with Simcyp Simulator V24

Understanding New Drug Applications (NDAs)

Understanding New Drug Applications (NDAs)

Обучение работе с программным обеспечением eCTD – Вопросы регулирования лекарственных средств

Обучение работе с программным обеспечением eCTD – Вопросы регулирования лекарственных средств

Regulatory Affairs Explained Series Episode 3 | Common Documents, Forms, ClinicalTrials.gov & More

Regulatory Affairs Explained Series Episode 3 | Common Documents, Forms, ClinicalTrials.gov & More

Webinar: Regulatory Affairs for QP and QA | Pharma Biotech

Webinar: Regulatory Affairs for QP and QA | Pharma Biotech

Основные понятия фармацевтического регулирования | Вопросы для собеседования по вопросам регулиро...

Основные понятия фармацевтического регулирования | Вопросы для собеседования по вопросам регулиро...

Designing Your Career as a Regulatory Professional

Designing Your Career as a Regulatory Professional

Electronic Common Technical Document (eCTD) and Study Data (7of15) RedI – May 29-30, 2019

Electronic Common Technical Document (eCTD) and Study Data (7of15) RedI – May 29-30, 2019

ICH M4-2. eCTD

ICH M4-2. eCTD

From Formulation to VBE: A Pirana & Simcyp VBE Case Study with Paliperidone Palmitate

From Formulation to VBE: A Pirana & Simcyp VBE Case Study with Paliperidone Palmitate

Regulatory Affairs Explained Series Episode 2 | Requesting Meetings, Meeting Types, Timelines & More

Regulatory Affairs Explained Series Episode 2 | Requesting Meetings, Meeting Types, Timelines & More

Biologics PBPK Platform in Simcyp Designer

Biologics PBPK Platform in Simcyp Designer

RegTalks about Regulatory Information Management Systems (RIMS)

RegTalks about Regulatory Information Management Systems (RIMS)

SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU

SNDS: Strengths, Limitations and Perspectives for the Largest and Richest Real-World Database in EU

© 2025 dtub. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]